Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)
Go back to Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.92 +2.65 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.27 | 52 Week High | $139.79 | |||
| Open | $285.73 | 52 Week Low | $82.07 | |||
| Day High | $290.33 | P/E | 667.26 | |||
| Day Low | $281.69 | EPS | $0.43 | |||
| Volume | 189,616 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 151.64 +1.78 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.86 | 52 Week High | $65.46 | |||
| Open | $151.50 | 52 Week Low | $47.97 | |||
| Day High | $152.69 | P/E | 103.16 | |||
| Day Low | $149.97 | EPS | $1.47 | |||
| Volume | 8,970,590 | |||||

